Our strategy

 

Iperboreal Pharma's strategy is to implement a cost-effective architecture, minimising infrastructure and overhead costs while maximising access to world-class expertise.

While ideational phases are carried on inside Iperboreal Pharma (therapeutic targets

identification, preclinical pharmacology, engineering, prototyping etc.), industrial development phases are carried out externally through commercial partnerships with companies specialized in each concerned field of activity.

In Iperboreal we believe that knowledge and research are the keystone for a successful strategy.

 

Our goals

 

Our goal is to develop research programs up to the industrialization stage and finalize commercial agreements (licensing, co-developing) and partnerships with pharmaceutical and biotech companies around the world. This scheme helps us to shorten the time needed to deliver our products to the market and generate profits and public benefits.

This goal is strictly connected to our intellectual property protection that is the main asset of every research based company.

We are also specialized as a preclinical CRO, or preclinical contract research organization, that provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution.

 

 

Why "Iperboreal"

 

An old map representing the mythical island of Thule, known to the ancient Greeks as the fabled land of Hyperborea.

 

On maps, Thule usually appears north or northwest of England and Ireland or in the northernmost parts of Asia. It has been associated with early reports of Greenland, Iceland, Norway, or the Shetland Islands.

“Never on land or by sea will you find the marvelous road to the feast of the Hyperborea”

                                         Pindar

 

PHONE

+39 085 2034834

ADDRESS

Via Piave 110/7

65122 PESCARA  ITALY

EMAIL

info@iperboreal.com

Our areas of interest

© 2017 Iperboreal Pharma. All rights reserved.

P.I. IT 01702360684

Our strategy

 

Iperboreal Pharma's strategy is to implement a cost-effective architecture, minimising infrastructure and overhead costs while maximising access to world-class expertise.

While ideational phases are carried on inside Iperboreal Pharma (therapeutic targets identification, preclinical pharmacology, engineering, prototyping etc.), industrial

development phases are carried out externally through commercial partnerships with companies specialized in each concerned field of activity.

In Iperboreal we believe that knowledge and research are the keystone for a successful strategy.

 

Our Goals

 

Our goal is to develop research programs up to the industrialization stage and finalize commercial agreements (licensing, co-developing) and partnerships with pharmaceutical and biotech companies around the world. This scheme helps us to shorten the time needed to deliver our products to the market and generate profits and public benefits.

 

 

This goal is strictly connected to our intellectual property protection that is the main asset of every research based company.

We are also specialized as a preclinical CRO, or preclinical contract research organization, that provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution.

 

a